Oncotype DX Breast recurrence score test
Estimated value
£192k
Awarded value
£192k
Awarded 19 Oct 2025
Suppliers
1
Lots
1
1 awarded
Published
24 Oct 2025
Deadline 30 Jun 2025
Description
Breast Cancer Recurrence Score Test contract ref PTH-22-21-11621 Contract extension taken 1st July 2025
Scope
- Reference
- CF-3233600D0O000000rwimUAA
- Total value
- £191,700 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2025 to 29 Jun 2026
- CPV classifications
- 33696200
Submission & procedure
- Submission deadline
- 30 Jun 2025, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£192k
Award date
19 Oct 2025
Contract start
30 Jun 2025
Contract end
29 Jun 2026
Awarded to